financetom
Business
financetom
/
Business
/
Airbnb asks NYC to reconsider regulations on short-term rentals
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbnb asks NYC to reconsider regulations on short-term rentals
Sep 3, 2024 4:41 AM

Sept 3 (Reuters) - Airbnb ( ABNB ) on Tuesday asked New

York City to reconsider regulations on short-term rentals that

went into effect in September 2023, citing higher prices for

travelers and zero impact on the housing market.

In a blog post, Airbnb ( ABNB ) said Local Law LL18, which states

hosts must be permanent occupants of the units being rented and

must register with the city before posting rentals, has "failed

to combat the housing crisis".

After the implementation of the law, the number of Airbnb ( ABNB )

listings allowing stays under 30 nights has fallen 83%,

according to an August report by data analytics firm Airdna.

Airbnb ( ABNB ), citing data from Apartment List, said vacancy rates

for apartments in New York City have remained virtually

unchanged at 3.4% since the law took effect.

The company also said the cost of travel has increased.

Hotel rates in New York City were up 7.4% year-over-year in

July, compared with 2.1% across the U.S., according to data from

Co-Star, Airbnb ( ABNB ) said.

"By rolling back parts of the law, the city can increase the

supply of accommodations for consumers, support resident hosts

and revitalize local businesses that depend on tourism dollars,"

Airbnb ( ABNB ) added.

The New York City mayor's office and the Office of Special

Enforcement were not immediately available for comment.

Last year, a New York judge dismissed the company's lawsuit

against New York City over the local law.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Major Pharma Stocks Down Amid Tariff Turmoil
Major Pharma Stocks Down Amid Tariff Turmoil
Apr 9, 2025
10:18 AM EDT, 04/09/2025 (MT Newswires) -- Major pharmaceutical stocks were down in recent Wednesday trading after multiple news outlets reported that President Donald Trump said Tuesday the US will impose a significant tariff on pharmaceutical imports. Shares of Johnson & Johnson ( JNJ ) dropped 2.4%, Pfizer ( PFE ) slid 2.5%, Biogen (BIIB) declined 1.9%, Bristol-Myers Squibb (...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: Amazon Considering $15 Billion Warehouse Expansion Plan
Market Chatter: Amazon Considering $15 Billion Warehouse Expansion Plan
Apr 9, 2025
10:18 AM EDT, 04/09/2025 (MT Newswires) -- Amazon.com ( AMZN ) is considering a $15 billion warehouse expansion plan to build around 80 new logistics facilities in US cities and rural areas, Bloomberg reported Wednesday, citing unnamed people familiar with the matter. The e-commerce giant is reaching out to potential capital partners to submit proposals for the project, including delivery...
OS Therapies Finalizes Acquisition of Advaxis Assets From Ayala Pharmaceuticals
OS Therapies Finalizes Acquisition of Advaxis Assets From Ayala Pharmaceuticals
Apr 9, 2025
10:18 AM EDT, 04/09/2025 (MT Newswires) -- OS Therapies ( OSTX ) said Wednesday it closed the acquisition of listeria-based cancer immunotherapy assets of Advaxis Immunotherapies from Ayala Pharmaceuticals. The biopharmaceutical company said it has acquired clinical, preclinical, and intellectual property assets, including immunotherapy programs for human papilloma virus-associated cancers, non-small cell lung cancer, and prostate cancer. OS Therapies (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved